106 related articles for article (PubMed ID: 26320538)
1. [Bone and Calcium Metabolisms Associated with Dental and Oral-Maxillofacial Diseases. Destructive bone resorption by osteoclasts and oral disease].
Nakamura M; Koide M; Nakamura H; Udagawa N
Clin Calcium; 2015 Sep; 25(9):1376-84. PubMed ID: 26320538
[TBL] [Abstract][Full Text] [Related]
2. [Bone and Calcium Metabolisms Associated with Dental and Oral-Maxillofacial Diseases. Bone remodeling and alveolar bone homeostasis].
Nakashima T
Clin Calcium; 2015 Aug; 25(8):1220-8. PubMed ID: 26224680
[TBL] [Abstract][Full Text] [Related]
3. The role of cathepsin K in oral and maxillofacial disorders.
Wen X; Yi LZ; Liu F; Wei JH; Xue Y
Oral Dis; 2016 Mar; 22(2):109-15. PubMed ID: 26458004
[TBL] [Abstract][Full Text] [Related]
4. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study.
O'Keefe RJ; Teot LA; Singh D; Puzas JE; Rosier RN; Hicks DG
Lab Invest; 1997 Apr; 76(4):457-65. PubMed ID: 9111508
[TBL] [Abstract][Full Text] [Related]
5. The role of cytokines in inflammatory bone loss.
Souza PP; Lerner UH
Immunol Invest; 2013; 42(7):555-622. PubMed ID: 24004059
[TBL] [Abstract][Full Text] [Related]
6. Bone disease and cytokines in idiopathic hypercalciuria: a review.
Santos AC; Lima EM; Oliveira EA; Simões e Silva AC
J Pediatr Endocrinol Metab; 2011; 24(7-8):405-10. PubMed ID: 21932573
[TBL] [Abstract][Full Text] [Related]
7. Roles of osteoclasts in alveolar bone remodeling.
Omi M; Mishina Y
Genesis; 2022 Sep; 60(8-9):e23490. PubMed ID: 35757898
[TBL] [Abstract][Full Text] [Related]
8. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
9. Potential pathways for bone resorption in human periodontal disease.
Hausmann E
J Periodontol; 1974 May; 45(5):338-43. PubMed ID: 4525514
[No Abstract] [Full Text] [Related]
10. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption.
Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E
J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406
[TBL] [Abstract][Full Text] [Related]
11. [Regulation of bone homeostasis by bone cells].
Nakashima T
Clin Calcium; 2013 Feb; 23(2):218-28. PubMed ID: 23354089
[TBL] [Abstract][Full Text] [Related]
12. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
[TBL] [Abstract][Full Text] [Related]
13. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Therapies for the Management of Inflammatory Bone Resorption in Periodontal Disease: A Review of Preclinical Studies.
Pavanelli ALR; de Menezes BS; Pereira EBB; de Souza Morais FA; Cirelli JA; de Molon RS
Biomed Res Int; 2022; 2022():5832009. PubMed ID: 35547360
[TBL] [Abstract][Full Text] [Related]
15. [The cytokine system of bone tissue].
Stilgren LS; Abrahamsen B; Abdallah BM; Jørgensen NR
Ugeskr Laeger; 2005 Feb; 167(8):874-8. PubMed ID: 15789838
[No Abstract] [Full Text] [Related]
16. Dissolution of the inorganic phase of bone leading to release of calcium regulates osteoclast survival.
Nielsen RH; Karsdal MA; Sørensen MG; Dziegiel MH; Henriksen K
Biochem Biophys Res Commun; 2007 Sep; 360(4):834-9. PubMed ID: 17631274
[TBL] [Abstract][Full Text] [Related]
17. Trigger osteoclast formation and activation: molecular treatment strategy of delayed tooth eruption.
Hua F; Zhang L; Chen Z
Med Hypotheses; 2007; 69(6):1222-4. PubMed ID: 17560733
[TBL] [Abstract][Full Text] [Related]
18. Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review.
Tateiwa D; Yoshikawa H; Kaito T
Cells; 2019 Aug; 8(8):. PubMed ID: 31382539
[TBL] [Abstract][Full Text] [Related]
19. Osteoclasts, rheumatoid arthritis, and osteoimmunology.
Sato K; Takayanagi H
Curr Opin Rheumatol; 2006 Jul; 18(4):419-26. PubMed ID: 16763464
[TBL] [Abstract][Full Text] [Related]
20. [Secondary osteoporosis or secondary contributors to bone loss in fracture. The relevance of immune system to bone metabolism].
Tanaka Y
Clin Calcium; 2013 Sep; 23(9):1265-70. PubMed ID: 23999361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
